×
About 17,174 results

ALLMedicine™ Hyperparathyroidism Center

Research & Reviews  8,135 results

Changes to bone mineral density, the trabecular bone score and hip structural analysis ...
https://doi.org/10.1186/s12882-020-02168-y
BMC Nephrology; Lin R, Vucak-Dzumhur M et. al.

Nov 27th, 2020 - Reduction in bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) occurs in secondary hyperparathyroidism associated with chronic kidney disease. BMD generally increases following parathyroidectomy, however longitudinal ch...

Re-operative parathyroidectomy: How many positive localization studies are required?
https://doi.org/10.1016/j.amjsurg.2020.11.027
American Journal of Surgery; Ramonell KM, Chen H et. al.

Nov 22nd, 2020 - Re-operative parathyroidectomy in patients with recurrent or persistent hyperparathyroidism can be challenging. We review our experience to determine the optimal number of localization studies prior to re-operation. From 2001 to 2019, 251 patients...

Muscle strength, physical performance, and metabolic changes after subtotal parathyroid...
https://doi.org/10.1016/j.surg.2020.10.002
Surgery Jimeno-Fraile J, Cao H et. al.

Nov 21st, 2020 - Hyperparathyroidism in patients on chronic hemodialysis presents with bone pain, pruritus, and extra-skeletal calcifications. Little attention has been paid to low plasma protein concentrations and muscle weakness in these patients. The present st...

Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for P...
https://doi.org/10.1001/jamaoto.2020.4021
JAMA Otolaryngology-- Head & Neck Surgery; Quinn AJ, Ryan ÉJ et. al.

Nov 19th, 2020 - Intraoperative parathyroid hormone (ioPTH) is a surgical adjunct that has been increasingly used during minimally invasive parathyroidectomy (MIP). Despite its growing popularity, to our knowledge a meta-analysis comparing MIP with ioPTH vs MIP wi...

Venous Air Embolism Identified by 18F-Fluorocholine Dual-Phase PET/CT.
https://doi.org/10.1097/RLU.0000000000003397
Clinical Nuclear Medicine; Cañete-Sánchez FM, Romero Robles LG et. al.

Nov 19th, 2020 - A 60-year-old woman with primary hyperparathyroidism with previous nonconclusive imaging studies was referred for F-fluorocholine (F-FCH) PET/CT as part of the preoperative diagnostic imaging workup to localize the adenoma before minimally invasiv...

see more →

Guidelines  3 results

The American Association of Endocrine Surgeons Guidelines for Definitive Management of ...
https://doi.org/10.1001/jamasurg.2016.2310
JAMA Surgery; Wilhelm SM, Wang TS et. al.

Oct 20th, 2016 - Primary hyperparathyroidism (pHPT) is a common clinical problem for which the only definitive management is surgery. Surgical management has evolved considerably during the last several decades. To develop evidence-based guidelines to enhance the ...

AME position statement: primary hyperparathyroidism in clinical practice.
https://www.ncbi.nlm.nih.gov/pubmed/22824948
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.

Jul 24th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,

2009 EANM parathyroid guidelines.
https://doi.org/10.1007/s00259-009-1131-z
European Journal of Nuclear Medicine and Molecular Imaging; Hindié E, Ugur O et. al.

May 27th, 2009 - The present guidelines were issued by the Parathyroid Task Group of the European Association of Nuclear Medicine. The main focus was imaging of primary hyperparathyroidism. Dual-tracer and single-tracer parathyroid scintigraphy protocols were disc...

see more →

Drugs  261 results see all →

Clinicaltrials.gov  8,547 results

Changes to bone mineral density, the trabecular bone score and hip structural analysis ...
https://doi.org/10.1186/s12882-020-02168-y
BMC Nephrology; Lin R, Vucak-Dzumhur M et. al.

Nov 27th, 2020 - Reduction in bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) occurs in secondary hyperparathyroidism associated with chronic kidney disease. BMD generally increases following parathyroidectomy, however longitudinal ch...

Re-operative parathyroidectomy: How many positive localization studies are required?
https://doi.org/10.1016/j.amjsurg.2020.11.027
American Journal of Surgery; Ramonell KM, Chen H et. al.

Nov 22nd, 2020 - Re-operative parathyroidectomy in patients with recurrent or persistent hyperparathyroidism can be challenging. We review our experience to determine the optimal number of localization studies prior to re-operation. From 2001 to 2019, 251 patients...

Muscle strength, physical performance, and metabolic changes after subtotal parathyroid...
https://doi.org/10.1016/j.surg.2020.10.002
Surgery Jimeno-Fraile J, Cao H et. al.

Nov 21st, 2020 - Hyperparathyroidism in patients on chronic hemodialysis presents with bone pain, pruritus, and extra-skeletal calcifications. Little attention has been paid to low plasma protein concentrations and muscle weakness in these patients. The present st...

Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for P...
https://doi.org/10.1001/jamaoto.2020.4021
JAMA Otolaryngology-- Head & Neck Surgery; Quinn AJ, Ryan ÉJ et. al.

Nov 19th, 2020 - Intraoperative parathyroid hormone (ioPTH) is a surgical adjunct that has been increasingly used during minimally invasive parathyroidectomy (MIP). Despite its growing popularity, to our knowledge a meta-analysis comparing MIP with ioPTH vs MIP wi...

Venous Air Embolism Identified by 18F-Fluorocholine Dual-Phase PET/CT.
https://doi.org/10.1097/RLU.0000000000003397
Clinical Nuclear Medicine; Cañete-Sánchez FM, Romero Robles LG et. al.

Nov 19th, 2020 - A 60-year-old woman with primary hyperparathyroidism with previous nonconclusive imaging studies was referred for F-fluorocholine (F-FCH) PET/CT as part of the preoperative diagnostic imaging workup to localize the adenoma before minimally invasiv...

see more →

News  209 results

NICE Guidance for GPs on Primary Hyperparathyroidism 
https://www.staging.medscape.com/viewarticle/930809

May 25th, 2020 - Primary hyperparathyroidism is a common condition. It can be difficult to diagnose and difficult to follow-up too, particularly in the setting of primary care. Prof Neil Gittoes looks at the National Institute for Health and Care Excellence guidel...

NICE Guidance for GPs on Primary Hyperparathyroidism 
https://www.medscape.com/viewarticle/930809

May 25th, 2020 - Primary hyperparathyroidism is a common condition. It can be difficult to diagnose and difficult to follow-up too, particularly in the setting of primary care. Prof Neil Gittoes looks at the National Institute for Health and Care Excellence guidel...

A 38-Year-Old Man With Back and Side Pain: Osmosis USMLE Study Question
https://www.medscape.com/viewarticle/899201_2

Feb 20th, 2020 - Nephrocalcinosis is a condition characterized by the calcification of the renal tubules that leads to renal insufficiency. This occurs via metastatic calcification, which means that calcium is deposited in normal tissues, rather than those that ha...

Nonuremic Calciphylaxis Triggered by Rapid Weight Loss and Hypotension
https://www.mdedge.com/dermatology/article/216159/mixed-topics/nonuremic-calciphylaxis-triggered-rapid-weight-loss-and/page/0/1?channel=45

Jan 27th, 2020 - Comment Background on Calciphylaxis Calciphylaxis is a rare but deadly disease that affects both ESRD patients receiving dialysis and patients without ESRD who have known risk factors for calciphylaxis, including female gender, white race, obesity.

Discovery Could Herald 'Game Changer' for Hyperparathyroidism
https://www.medscape.com/viewarticle/914099

Jun 6th, 2019 - A study in animals suggests hope may be on the horizon for a novel agent to treat hyperparathyroidism. Mice that were deficient in semaphorin3d (Sema3d), a secreted protein, developed an abnormally large parathyroid gland, but inhibiting a signali...

see more →

Patient Education  19 results see all →